Protalix BioTherapeutics Inc (FRA:PBDA)
€ 2.114 0.097 (4.81%) Market Cap: 158.85 Mil Enterprise Value: 137.93 Mil PE Ratio: 0 PB Ratio: 5.08 GF Score: 46/100

Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts

  • 1